Figma Shares Indicated To Open $105/$110
DUBLIN - Perrigo Company plc (NYSE:PRGO) announced Wednesday that its Board of Directors has declared a quarterly dividend of $0.29 per share, according to a company press release.
The dividend will be payable on September 16, 2025, to shareholders of record as of August 29, 2025.
Perrigo, which describes itself as a leading provider of Consumer Self-Care Products, focuses on health and wellness solutions primarily in North America and Europe. The company operates in the over-the-counter self-care market with both store brand private label offerings and branded products. With a market capitalization of $3.86 billion and a strong current ratio of 2.36, InvestingPro data shows the company maintains a GOOD overall financial health score.
The quarterly dividend announcement comes as part of the company’s regular financial activities. Perrigo’s business model combines store brand private label products with branded offerings including Opill, Mederma, Compeed, EllaOne, and Jungle Formula.
The dividend declaration represents a continuation of Perrigo’s existing shareholder return program. The company made the announcement in a press release that also contained forward-looking statements regarding its business operations and financial condition.
In other recent news, Perrigo Company reported its first-quarter 2025 earnings, surpassing analyst expectations, although its revenue did not meet estimates. This performance was marked by a substantial 106% increase in earnings per share, even as revenue experienced a 3.5% decline. The company is also undergoing strategic changes, having agreed to sell its Dermacosmetics business to Kairos Bidco, backed by KKR, for up to €327 million. The sale includes an upfront cash payment of €300 million and up to €27 million in milestone payments over three years.
In executive developments, Perrigo announced that Matt Winterman will become the new Executive Vice President, succeeding Ron Janish, who plans to retire in September 2025. Jefferies recently adjusted Perrigo’s stock price target to $30 from $31, maintaining a Hold rating. This adjustment followed the company’s mixed financial results, reflecting its ability to enhance profitability despite a decline in revenue. These developments represent Perrigo’s ongoing efforts to streamline its operations and adapt to market conditions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.